Business Wire

Money20/20 Unveils Global Powerhouse Jury for Inaugural Money Awards

21.5.2025 13:48:00 CEST | Business Wire | Press Release

Share

Money20/20, the world's leading fintech show, and the place where money does business, today announced its inaugural jury for The Money Awards, featuring an unprecedented assembly of distinguished leaders from across the global financial technology ecosystem from traditional banks, fintechs, neobanks, venture capitalists, and the world’s most influential brands. The jury represents in-depth knowledge and expertise from around the world spanning North America, Europe, Latin America, Asia, Middle-East and Africa, reinforcing the awards' position as the definitive global benchmark for fintech excellence.

The jury lineup for the Money Awards are:

Banking Award

Jury President:
Joanne Hannaford, Chief Information Officer & Chief Product Officer Corporate Bank, Deutsche Bank

Jury Members:
Annerie Vreugdenhil, Chief Commercial Officer Personal & Business Banking, ABN AMRO N.V.
Elizabeth Jimenez, Senior Vice President, Strategic Risk, Citi
Glauber Mota, CEO, Revolut
John Piazza, Head of Product, Newline by Fifth Third
Lukasz Strozek, Chief Technology Officer, LendingClub
Nobutake Suzuki, President & CEO, MUFG Innovation Partners Co., Ltd.
Tosin Eniolorunda, Founder & Group CEO, Moniepoint Inc.

Diamond Award

Jury President:
Lynn Martin, President, NYSE Group

Jury Members:
Manolo Sánchez, CEO, Adelante Ventures LLC
Nico Kersten, CEO & Managing Director, Mercedes pay GmbH
Suzan Kereere, President, Global Markets, PayPal
Tim Shen, CEO, LianLian Global

Payments Award

Jury President:
Howard R. Fields, Chief Ethics & Compliance Officer, Mastercard

Jury Members:
Brigette Korney, Global Head of Risk, Adyen
Camilla Bullock, CEO, Emerging Payments Association Asia
Meron Colbeci, Chief Product Officer, Checkout.com
Neetika Bansal, Head of Money Management & Crypto, Stripe
Olugbenga Agboola, Founder & CEO, Flutterwave Inc.
Pebbles Sy, Chief Technology & Operations Officer, GCash
Prajit Nanu, CEO, Nium
Theresa Gongora, Executive Vice President, Merchant Solutions, Global Payments, Inc.

Partnerships & Strategic Alliance Award

Jury President:
Anthony Thomas, Managing Director, FinTech, Delivery Hero

Jury Members:
Jose Antonio Murillo, CEO, RappiCard
Joyce Lim, Director of Global Payments, Expedia Group
Mariette Ferreira, Chief Marketing Officer, PPRO
Mohammed Alzubi, Founder & Managing Partner, Nama Ventures
Ranjit Sarai, VP Digital & Ecosystem, Canada, Western Union
Sarah Kocianski, CEO, FinTech Wales
Suvo Sarkar, Host, Money Majlis podcast, Founder & CEO, 3D Advisory

Startup Award

Jury President:
Chetan Puttagunta, General Partner, Benchmark

Jury Members:
Annie Guo, CEO, Silkpay
Mareme Dieng, Partner, 500 Global
Mariel Vasquez, Head of Innovation & Growth, HSBC Mexico
Mark Fiorentino, Partner, Bain Capital Ventures
Noam Inbar, Partner, Viola Fintech
Steph Choo, General Partner, Portage
Vicky Bindra, CEO, Trulioo
Vishnu Acharya, Head of Strategy, M&A, Investments, Razorpay

"The Money Awards Jury plays a vital role in setting the global benchmark for recognizing transformative innovation across the fintech ecosystem.The caliber and diversity of our jury panel reflects the truly global nature of financial innovation," said Grania Chesterton, Vice President of Awards at Money20/20. "By bringing together voices from established financial capitals and emerging fintech hubs, we're ensuring that The Money Awards recognize excellence that transcends geographical boundaries and represents the future of finance on a truly global scale."

Jurors will evaluate submissions through a transparent and impartial process that includes online reviews followed by in-person deliberations at Money20/20 USA. The winners will be announced live at Money20/20 USA in Las Vegas in October, ensuring global recognition.

Winners will receive a bespoke trophy and benefit from year-round visibility through Money20/20’s platforms, including exclusive speaking opportunities, media exposure, investor visibility, and networking at Money20/20 shows worldwide. Entries are open now and are live until the 29th of July.

For more information about The Money Awards, visit www.money2020.com/award.

About Money20/20

Launched by industry insiders in 2012, Money20/20 has rapidly become the heartbeat of the global fintech ecosystem. Over the last decade, the most innovative, fast-moving ideas and companies have driven their growth on our platform. Mastercard, Wise, J.P. Morgan, SHIELD, Convera, Stripe, Google, VISA, Adyen, and more make transformational deals and raise their global profile with us. Money20/20 attracts leaders from the world’s greatest banks, payments companies, VC firms, regulators and media platforms: convening to cut industry-shaping deals, build world-changing partnerships and unlock future-defining opportunities in Bangkok (22-24 April 2025) in Amsterdam (3-5 June 2025), in Riyadh ( 15-17 September 2025), and in Las Vegas (26-29 October 2025). Money20/20 is where the world’s fintech leaders convene to grow their businesses. Money20/20 is part of Informa Festivals. Follow Money20/20 on X and LinkedIn for show developments and updates. We’re Where Money Does Business. Follow Money20/20 on X for show developments and updates. You can also find us on LinkedIn at Money20/20.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250521771868/en/

Contacts

For more information, please contact:
Tina Loncaric
Global Head of PR
Money20/20
tina@money2020.com
M: +1 469 288 5556

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release

inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye